chr3-133400213-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_003571.4(BFSP2):āc.130A>Gā(p.Thr44Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003571.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BFSP2 | NM_003571.4 | c.130A>G | p.Thr44Ala | missense_variant | 1/7 | ENST00000302334.3 | |
BFSP2 | XM_017007315.2 | c.130A>G | p.Thr44Ala | missense_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BFSP2 | ENST00000302334.3 | c.130A>G | p.Thr44Ala | missense_variant | 1/7 | 1 | NM_003571.4 | P1 | |
BFSP2 | ENST00000513441.1 | n.140A>G | non_coding_transcript_exon_variant | 1/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251138Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135768
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461736Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727158
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2023 | The c.130A>G (p.T44A) alteration is located in exon 1 (coding exon 1) of the BFSP2 gene. This alteration results from a A to G substitution at nucleotide position 130, causing the threonine (T) at amino acid position 44 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at